RxDoctor Payments Data

Bonny Voyles

Family · Moultrie, GANPI 1851627624

Payments from drug & device makers

$3,614in general payments, 2019–2025

Across 179 payments — averaging $20.19 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$515
  • Novo Nordisk$473
  • Pfizer$395
  • Dexcom, Inc.$391
  • AstraZeneca$347
  • Amgen$211
  • plus $1K from 21 others

What the payments were for

  • Food & beverage$3,614100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,614 in reported general payments places this provider in the 85th percentile of 6,258 family providers in Georgia.

See all family providers in Georgia

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide18$35,038
MounjaroTirzepatide30$33,723
TradjentaLinagliptin27$33,457
EliquisApixaban16$17,320
LinzessLinaclotide19$16,088
JardianceEmpagliflozin14$10,357
JanuviaSitagliptin Phosphate11$8,276
Lantus SolostarInsulin Glargine,hum.Rec.Anlog55$7,649
JanumetSitagliptin Phos/Metformin Hcl12$6,762
Omeprazole82$1,043
Rosuvastatin Calcium134$960
Droplet Pen NeedlePen Needle, Diabetic14$837
Ulticare Pen NeedlePen Needle, Diabetic12$791
Albuterol Sulfate HfaAlbuterol Sulfate30$783
Pantoprazole Sodium81$742

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Boehringer IngelheimTradjenta, Jardiance$161$43,81341 claims
Novo NordiskOzempic$473$35,03818 claims
Lilly USA, LLCMounjaro$140$33,72330 claims
PfizerEliquis$395$17,32016 claims
AbbVieLinzess, Synthroid$515$16,32830 claims
MerckJanuvia, Janumet$17$15,03923 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 6,258 family providers in Georgia.

Other family in Moultrie

See the full list for Georgia

Where these figures come from

Is this you, or does something look wrong? →